Lumexa Imaging Holdings, Inc. (LMRI)
NASDAQ:LMRI
Want to see LMRI full AI Analyst Report?
LMRI Stock Chart & Stats
$9.66
--
Market closed
$9.66
--
Day’s Range― - ―
52-Week Range$7.23 - $19.45
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.53M
Market Cap
$961.10M
Enterprise Value$1.86B
Total Cash (Recent Filing)$58.83M
Total Debt (Recent Filing)$960.90M
Price to Earnings (P/E)―
Beta2.22
Next Earnings
May 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.38
Shares Outstanding96,110,040
10 Day Avg. Volume1,530,126
30 Day Avg. Volume1,530,126
Financial Highlights & Ratios
PEG Ratio0.82
Price to Book (P/B)2.24
Price to Sales (P/S)1.28
P/FCF Ratio-205.07
Enterprise Value/Market Cap1.94
Enterprise Value/Revenue6.96
Enterprise Value/Gross Profit62.69
Enterprise Value/Ebitda378.31
Forecast
1Y Price Target
$18.00Price Target Upside86.34% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)0.78
Revenue Forecast (FY)$1.06B
Bulls Say, Bears Say
Bulls Say
Revenue & Adjusted EBITDA GrowthSustained top-line growth with simultaneous adjusted EBITDA expansion indicates durable demand for advanced outpatient imaging. This revenue and margin momentum supports operating leverage, funds network expansion, and underpins a credible multi-year path to consistent profitability if trends continue.
Meaningful Deleveraging And Liquidity BuildMaterial debt paydown and higher cash improved credit metrics and lower interest costs, increasing financial flexibility. Structural deleveraging reduces refinancing risk, frees cash for capex or tuck-ins, and strengthens runway to execute expansion and tech investments over the next several years.
Technology & Throughput ImprovementsPersistent productivity gains from FastScan, virtual cockpit and AI materially raise capacity per center, lower unit labor costs, and shorten de‑novo breakeven. Structural tech adoption supports scalable growth, higher acuity mix and margin sustainability as the network expands over time.
Bears Say
Ongoing GAAP Net LossesDespite operating improvements, persistent GAAP losses indicate the company has not fully converted operating performance into bottom-line profitability. Continued net losses can erode equity, limit retained earnings, and may necessitate further financing until sustained net profits are achieved.
Weakened Cash Generation In 2025Negative free cash flow and falling operating cash flow signal weaker earnings-to-cash conversion and higher working capital strain. Structurally, this raises reliance on external capital, constrains reinvestment capacity, and increases sensitivity to funding costs over the medium term.
High Capital Intensity & Limited CapEx VisibilityOngoing large capital requirements for new centers and equipment create durable cash needs. Lack of clear near-term CapEx guidance increases modeling risk and could delay free cash flow normalization, stressing funding plans despite recent deleveraging progress.
Lumexa Imaging Holdings, Inc. News
LMRI FAQ
What was Lumexa Imaging Holdings, Inc.’s price range in the past 12 months?
Lumexa Imaging Holdings, Inc. lowest stock price was $7.23 and its highest was $19.45 in the past 12 months.
What is Lumexa Imaging Holdings, Inc.’s market cap?
Lumexa Imaging Holdings, Inc.’s market cap is $961.10M.
When is Lumexa Imaging Holdings, Inc.’s upcoming earnings report date?
Lumexa Imaging Holdings, Inc.’s upcoming earnings report date is May 12, 2026 which is in 8 days.
How were Lumexa Imaging Holdings, Inc.’s earnings last quarter?
Lumexa Imaging Holdings, Inc. released its earnings results on Mar 26, 2026. The company reported -$0.38 earnings per share for the quarter, missing the consensus estimate of $0.046 by -$0.426.
Is Lumexa Imaging Holdings, Inc. overvalued?
According to Wall Street analysts Lumexa Imaging Holdings, Inc.’s price is currently Undervalued.
Does Lumexa Imaging Holdings, Inc. pay dividends?
Lumexa Imaging Holdings, Inc. does not currently pay dividends.
What is Lumexa Imaging Holdings, Inc.’s EPS estimate?
Lumexa Imaging Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lumexa Imaging Holdings, Inc. have?
Lumexa Imaging Holdings, Inc. has 96,110,040 shares outstanding.
What happened to Lumexa Imaging Holdings, Inc.’s price movement after its last earnings report?
Lumexa Imaging Holdings, Inc. reported an EPS of -$0.38 in its last earnings report, missing expectations of $0.046. Following the earnings report the stock price went down -29.837%.
Which hedge fund is a major shareholder of Lumexa Imaging Holdings, Inc.?
Currently, no hedge funds are holding shares in LMRI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Lumexa Imaging Holdings, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$18.00 (86.34% Upside)
$18.00 (86.34% Upside)
Blogger Sentiment
Bullish
LMRI Sentiment 100%
Sector Average ―
Sector Average ―
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 2.9%
Last 30 Days ▼ 2.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
-18.34%
Trailing 12-Months
Asset Growth
5.86%
Trailing 12-Months
Company Description
Lumexa Imaging Holdings, Inc.
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. The company was founded in 2018 and is based in Raleigh, North Carolina.
LMRI Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presents a predominantly positive operational and financial picture: healthy revenue and adjusted EBITDA growth, margin expansion, strong cash generation, significant deleveraging following the IPO, record de novo openings, and meaningful progress on technology and JV partnerships. Near-term challenges include Q1 volume timing effects from pull-forwards and weather, GAAP losses driven by transaction costs, ongoing capital intensity with limited forward CapEx detail, and continued stock-based compensation expense. Management maintained full-year guidance and provided EPS guidance, signaling confidence in recovering lost volumes and delivering on 2026 plans.View all LMRI earnings summariesLMRI Stock 12 Month Forecast
Average Price Target
$18.00
▲(86.34% Upside)
Ownership Overview
0.43% Insiders
11.52% Mutual Funds
0.15% Other Institutional Investors
85.54% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---